Align Technology Launches New Invisalign System
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 22 2025
0mins
Should l Buy ALGN?
Align Technology has launched a new Invisalign System in the Philippines, specifically designed for Class II malocclusion in children and teenagers. This innovative treatment integrates mandibular advancement with occlusal blocks, enhancing treatment efficiency and patient comfort.
The new system addresses a significant portion of malocclusions globally, which are prevalent among young patients. By expanding its market presence in the Asia-Pacific region, Align aims to attract more young patients seeking effective orthodontic solutions.
Clinical data indicates that the new system's treatment outcomes are comparable to traditional methods, while the patented SmartTrack™ material used in the occlusal blocks ensures increased comfort and compliance, which are crucial for successful treatment.
This strategic launch not only enhances Align's product offerings but also reinforces its commitment to providing comprehensive orthodontic solutions for growing patients, potentially driving further growth in the company's market share.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALGN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALGN
Wall Street analysts forecast ALGN stock price to rise
13 Analyst Rating
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 169.430
Low
169.00
Averages
198.70
High
220.00
Current: 169.430
Low
169.00
Averages
198.70
High
220.00
About ALGN
Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
U.S. Stocks Show Minor Fluctuations Amid Rising Oil Prices
- Oil Price Surge Impacts Market: Despite the IEA's decision to release 400 million barrels from strategic reserves to address supply disruptions in the Strait of Hormuz, oil prices rose by 4.6%, exerting downward pressure on the stock market, particularly amid the ongoing conflict in Iran.
- Limited Impact from Inflation Data: February's CPI rose 2.4% year-over-year, with core CPI at 2.5%, which, while close to five-year lows, remains above the Fed's 2% target, leading to a muted market reaction and reflecting investor concerns over future inflation pressures.
- Mixed Performance in Tech Stocks: Following Oracle's strong AI demand announcement, tech stocks received a boost with Oracle's shares rising over 9%, yet other tech stocks like IBM and Microsoft saw slight declines, indicating ongoing uncertainty in investor confidence within the tech sector.
- Private Credit Market Struggles: JPMorgan Chase's restriction on lending to private credit funds has led to an exodus of investors from the $1.8 trillion sector, exacerbating market uncertainty and negatively impacting overall stock performance.
See More
Analysis of Align Technology Options Trading
- Options Selling Risk: Selling puts on Align Technology does not provide the same upside potential as owning shares, as the put seller only acquires shares if the contract is exercised, limiting their upside to a 5% annualized return unless the stock drops to $125.
- Cost Basis Analysis: If Align Technology's stock falls by 32.1%, resulting in the contract being exercised, the seller's cost basis would be $113.00 per share after commissions, meaning their profit is limited to the premium collected.
- Volatility Assessment: The trailing twelve-month volatility for Align Technology is calculated at 60%, which, when combined with fundamental analysis, can help assess whether selling the January 2028 put at the $125 strike is a worthwhile risk.
- Market Trading Dynamics: On Friday afternoon, the put volume among S&P 500 components reached 1.33 million contracts, matching call volume, indicating a higher-than-normal interest in put options, reflecting market concerns about downside risks.
See More
HSBC Upgrades Align Technology Rating
- Stock Price Increase: Align Technology (ALGN) shares rose over 2% in recent Monday trading, reflecting market optimism regarding the company's future performance, particularly following HSBC's upgrade.
- Impact of Rating Upgrade: HSBC's upgrade may attract more investor attention to Align Technology, enhancing its market liquidity and stock price stability, thereby strengthening the company's competitive position in the medical device sector.
- Positive Market Reaction: Investors responded positively to HSBC's rating adjustment, indicating increased market confidence in Align Technology, which could facilitate more capital inflow and further drive stock price appreciation.
- Strategic Implications: This rating upgrade not only enhances Align Technology's market image but may also provide funding support for future business expansion and product innovation, helping the company capture a larger share of the rapidly growing digital dentistry market.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, including upgrades, downgrades, and initiations, reflecting varying market perspectives and future expectations for these firms.
- Market Reaction Insight: While specific company names are not disclosed, changes in analyst ratings typically influence investor decisions, potentially leading to price volatility in the affected stocks.
- Investor Focus: Investors considering buying RBLX stock should pay attention to analysts' opinions, as these insights may impact market sentiment and stock performance.
- Rating Change Transparency: Benzinga provides a comprehensive view of analyst rating changes, assisting investors in obtaining complete information to make more informed investment decisions.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- Upgrades and Downgrades: While specific stock names are not mentioned, such rating changes typically lead to price fluctuations in the affected stocks, prompting investors to closely monitor these adjustments for portfolio optimization.
- Market Reaction Expectations: Analyst rating adjustments may trigger short-term market reactions, especially when investor sentiment is sensitive towards certain stocks, thereby impacting overall market sentiment.
- Information Access Channels: Investors can access a comprehensive view of rating changes through Benzinga's analyst ratings page, enabling them to make more informed investment decisions.
See More
Major Wall Street Rating Updates on Monday
- Robinhood Upgrade: Wolfe upgraded Robinhood from Peer Perform to Outperform to capitalize on the recent selloff due to deteriorating sentiment in the crypto ecosystem, indicating that investors should seize the buying opportunity.
- Bullish on TeraWulf and Cipher Mining: Morgan Stanley initiated coverage on TeraWulf and Cipher Mining with an Overweight rating, citing significant upside potential from attractive valuations in the bitcoin mining sector.
- Timken's New CEO Drives Growth: KeyBanc upgraded Timken from Sector Weight to Overweight with a $130 price target, primarily based on expectations that new CEO Lucian Boldea will enhance organic growth initiatives and improve margins.
- Align Technologies Brand Strength: HSBC upgraded Align Technologies from Hold to Buy, emphasizing that its strong brand presence and R&D culture are key long-term growth drivers in the orthodontics market.
See More
U.S. Stocks Show Minor Fluctuations Amid Rising Oil Prices
- Oil Price Surge Impacts Market: Despite the IEA's decision to release 400 million barrels from strategic reserves to address supply disruptions in the Strait of Hormuz, oil prices rose by 4.6%, exerting downward pressure on the stock market, particularly amid the ongoing conflict in Iran.
- Limited Impact from Inflation Data: February's CPI rose 2.4% year-over-year, with core CPI at 2.5%, which, while close to five-year lows, remains above the Fed's 2% target, leading to a muted market reaction and reflecting investor concerns over future inflation pressures.
- Mixed Performance in Tech Stocks: Following Oracle's strong AI demand announcement, tech stocks received a boost with Oracle's shares rising over 9%, yet other tech stocks like IBM and Microsoft saw slight declines, indicating ongoing uncertainty in investor confidence within the tech sector.
- Private Credit Market Struggles: JPMorgan Chase's restriction on lending to private credit funds has led to an exodus of investors from the $1.8 trillion sector, exacerbating market uncertainty and negatively impacting overall stock performance.
See More
Analysis of Align Technology Options Trading
- Options Selling Risk: Selling puts on Align Technology does not provide the same upside potential as owning shares, as the put seller only acquires shares if the contract is exercised, limiting their upside to a 5% annualized return unless the stock drops to $125.
- Cost Basis Analysis: If Align Technology's stock falls by 32.1%, resulting in the contract being exercised, the seller's cost basis would be $113.00 per share after commissions, meaning their profit is limited to the premium collected.
- Volatility Assessment: The trailing twelve-month volatility for Align Technology is calculated at 60%, which, when combined with fundamental analysis, can help assess whether selling the January 2028 put at the $125 strike is a worthwhile risk.
- Market Trading Dynamics: On Friday afternoon, the put volume among S&P 500 components reached 1.33 million contracts, matching call volume, indicating a higher-than-normal interest in put options, reflecting market concerns about downside risks.
See More
HSBC Upgrades Align Technology Rating
- Stock Price Increase: Align Technology (ALGN) shares rose over 2% in recent Monday trading, reflecting market optimism regarding the company's future performance, particularly following HSBC's upgrade.
- Impact of Rating Upgrade: HSBC's upgrade may attract more investor attention to Align Technology, enhancing its market liquidity and stock price stability, thereby strengthening the company's competitive position in the medical device sector.
- Positive Market Reaction: Investors responded positively to HSBC's rating adjustment, indicating increased market confidence in Align Technology, which could facilitate more capital inflow and further drive stock price appreciation.
- Strategic Implications: This rating upgrade not only enhances Align Technology's market image but may also provide funding support for future business expansion and product innovation, helping the company capture a larger share of the rapidly growing digital dentistry market.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, including upgrades, downgrades, and initiations, reflecting varying market perspectives and future expectations for these firms.
- Market Reaction Insight: While specific company names are not disclosed, changes in analyst ratings typically influence investor decisions, potentially leading to price volatility in the affected stocks.
- Investor Focus: Investors considering buying RBLX stock should pay attention to analysts' opinions, as these insights may impact market sentiment and stock performance.
- Rating Change Transparency: Benzinga provides a comprehensive view of analyst rating changes, assisting investors in obtaining complete information to make more informed investment decisions.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- Upgrades and Downgrades: While specific stock names are not mentioned, such rating changes typically lead to price fluctuations in the affected stocks, prompting investors to closely monitor these adjustments for portfolio optimization.
- Market Reaction Expectations: Analyst rating adjustments may trigger short-term market reactions, especially when investor sentiment is sensitive towards certain stocks, thereby impacting overall market sentiment.
- Information Access Channels: Investors can access a comprehensive view of rating changes through Benzinga's analyst ratings page, enabling them to make more informed investment decisions.
See More
Major Wall Street Rating Updates on Monday
- Robinhood Upgrade: Wolfe upgraded Robinhood from Peer Perform to Outperform to capitalize on the recent selloff due to deteriorating sentiment in the crypto ecosystem, indicating that investors should seize the buying opportunity.
- Bullish on TeraWulf and Cipher Mining: Morgan Stanley initiated coverage on TeraWulf and Cipher Mining with an Overweight rating, citing significant upside potential from attractive valuations in the bitcoin mining sector.
- Timken's New CEO Drives Growth: KeyBanc upgraded Timken from Sector Weight to Overweight with a $130 price target, primarily based on expectations that new CEO Lucian Boldea will enhance organic growth initiatives and improve margins.
- Align Technologies Brand Strength: HSBC upgraded Align Technologies from Hold to Buy, emphasizing that its strong brand presence and R&D culture are key long-term growth drivers in the orthodontics market.
See More
